Compound 567
Identifiers
- Canonical SMILES:
CN(C)CCC[C@](O)(c1ccccc1)c1ccc(OCCc2ccc(cc2)-c2ccc(cc2)C(O)=O)cc1
- IUPAC name:
4-[4-[2-[4-[4-(dimethylamino)-1-hydroxy-1-phenylbutyl]phenoxy]ethyl]phenyl]benzoic acid
- InChi:
InChI=1S/C33H35NO4/c1-34(2)23-6-22-33(37,29-7-4-3-5-8-29)30-17-19-31(20-18-30)38-24-21-25-9-11-26(12-10-25)27-13-15-28(16-14-27)32(35)36/h3-5,7-20,37H,6,21-24H2,1-2H3,(H,35,36)/t33-/m0/s1
- InChiKey:
IBFCGGCXMALXFO-XIFFEERXSA-N
External links
168318168 |
26362484 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 4.92 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 509.26 g/mol | |||
HBA | 5 | |||
HBD | 2 | |||
HBA + HBD | 7 | |||
AlogP | 3.80 | |||
TPSA | 70.00 | |||
RB | 12 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6514 | Ansofaxine | DB15052 | |
0.5979 | Fexofenadine | DB00950 | |
0.5758 | Lifibrol | DB12448 | |
0.5728 | Dyclonine | DB00645 | |
0.5714 | Darifenacin | DB00496 | |
0.5691 | {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone | DB07237 | |
0.5591 | Terfenadine | DB00342 | |
0.5504 | 2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid | DB04405 | |
0.5489 | Adomeglivant | DB11704 | |
0.5439 | Fesoterodine | DB06702 | |
0.5429 | Adapalene | DB00210 | |
0.5376 | Diphenidol | DB01231 | |
0.5340 | (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid | DB08121 | |
0.5312 | Chlorotoxin I-131 | DB05462 | |
0.5294 | Venlafaxine | DB00285 |